Elron sells entire Galil Medical stake

Galil Medical is developing cryotherapy treatments for cancer.

Nochi Dankner-controlled IDB Holding Corp. Ltd. (TASE:IDBH) technology holding company Elron Electronic Industries Ltd. (Pink Sheets: ELRNF; TASE: ELRN) is continuing the sell-off of assets with the sale of its full stake in cryotherapy cancer treatment developer Galil Medical Ltd.. Elron's parent company Discount Investment Corporation (TASE: DISI) and Rafael Development Corporation (RDC - owned in equal shares by Elron and Rafael Advanced Defense Systems Ltd.) are also selling their shares in the company. They are selling their aggregate stake in Galil Medical to its other shareholders for $1.33 million altogether.

Galil Medical is currently raising $6.4 million from its shareholders, including Elron, Discount Investment, and RDC. Galil Medical will convert existing debt owed to the three into senior shares. When the fundraising is complete, Elron will own 8.6% of Galil Medical, Discount Investment will own 9.2%, and RDC will own 12.34%.

According to Galil Medical, its other shareholders are US healthcare venture capital firms Thomas, McNerney & Partners, Investor Growth Capital, and Vertical Group.

Galil Medical was founded in 1997 on the basis of technology developed at Rafael and commercialized through RDC, and is considered a promising start-up.

If within two years, Galil Medical is sold to, or merged with, a third party, Elron, Discount Investment, and RDC will be eligible for additional payment based on the difference between a third of the proceeds of that transaction and the $1.33 million.

Elron has already sold a number of assets in the past few months, including the intellectual property of DV3 Ltd., fabless semiconductor developers Sela Ltd. and ChipX Ltd., and its stake in Internet services provider and international calls carrier NetVision Ltd. (TASE: NTSN), a sister company. The company has put insulin pump developer Medingo Ltd., one of its core businesses, up for sale.

Elron's share closed at $8.43 in New York yesterday, and the share was unchanged today on the TASE at NIS 30.89.

Published by Globes [online], Israel business news - www.globes-online.com - on March 15, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Joseph Papa Perrigo up for sale

The pharmaceutical firm is seeking a merger at a premium on its $20 billion market cap.

Twitter Facebook Linkedin RSS Newsletters גלובס